Browse All

Current Filters

CLEAR FILTER x

TITLE

Paraquat Exposure and Parkinson’s Disease Risk in the United States: A Meta-analysis of Epidemiologic Studies

Effectiveness of Foslevodopa/Foscarbidopa in Subgroups of Patients Earlier within Advanced Parkinson’s Disease in an Interim Dataset of ROSSINI

Foslevodopa/Foscarbidopa Improves Pain in People With Advanced Parkinson’s Disease Who Have Uncontrolled Motor Fluctuations: Interim Results From the Real-World ROSSINI Study

Efficacy and Predictors of Discontinuation of Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion Therapy in a Parkinson’s Disease Cohort